Page last updated: 2024-08-26

dibenzylidene acetone and Colonic Neoplasms

dibenzylidene acetone has been researched along with Colonic Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aggarwal, BB; Prasad, S; Ravindran, J; Yadav, VR1

Other Studies

1 other study(ies) available for dibenzylidene acetone and Colonic Neoplasms

ArticleYear
ROS and CHOP are critical for dibenzylideneacetone to sensitize tumor cells to TRAIL through induction of death receptors and downregulation of cell survival proteins.
    Cancer research, 2011, Jan-15, Volume: 71, Issue:2

    Topics: Apoptosis; Cell Line, Tumor; Cell Survival; Colonic Neoplasms; Down-Regulation; Drug Synergism; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; HCT116 Cells; HT29 Cells; Humans; Mitogen-Activated Protein Kinases; Pentanones; PPAR gamma; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; Receptors, Death Domain; TNF-Related Apoptosis-Inducing Ligand; Transcription Factor CHOP; Tumor Necrosis Factor Decoy Receptors; Up-Regulation

2011